Urogen Pharma Ltd. · NASDAQ:URGN

Schoenberg Mark sold 871 Urogen Pharma Ltd. shares (Form 4)

Traded Sep 7 to Sep 8, 2026 · Filed Sep 9, 2026

From Sep 7 to Sep 8, 2026, Schoenberg Mark (Chief Medical Officer) sold 871 Urogen Pharma Ltd. shares at US$42.92 for US$37,383, leaving 59,882 shares. Filed Sep 9, 2026 (Form 4).

Sold: 871 shares
Price: US$42.92
Value: US$37,383
Holding after: 59,882 shares
Trading plan: No
Role: Chief Medical Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 7, 2026	Ordinary Shares	Option exercise	1,667		60,753	Direct
Sep 8, 2026	Ordinary Shares	Sale	871	US$42.92	59,882	Direct

Source

View original at SEC

Related